Capstone Financial Advisors, Inc. Amgen Inc Transaction History

Capstone Financial Advisors, Inc.

$1.51 Billion
Q2 2024

A detailed history of Capstone Financial Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 1,928 shares of AMGN stock, worth $625,366. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,928

Previous 1,925 0.16%

Holding current value

$625,366

Previous $547,000 10.05%

% of portfolio

0.04%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $788 - $957	3 Added 0.16%	1,928 $602,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $12,636 - $15,254	47 Added 2.5%	1,925 $547,000
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $767 - $865	3 Added 0.16%	1,878 $540,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $35,202 - $43,705	-161 Reduced 7.91%	1,875 $503,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $15,213 - $17,989	-71 Reduced 3.37%	2,036 $452,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $33,191 - $40,454	-147 Reduced 6.52%	2,107 $509,000
Q4 2022 Feb 15, 2023	SELL	$229.03 - $291.01 $70,083 - $89,049	-306 Reduced 11.95%	2,254 $591,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $8,753 - $9,872	-39 Reduced 1.5%	2,560 $577,000
Q2 2022 Sep 02, 2022	BUY	$230.71 - $256.74 $1,153 - $1,283	5 Added 0.19%	2,599 $632,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $2,192 - $2,425	10 Added 0.39%	2,594 $627,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $58,669 - $67,142	295 Added 12.89%	2,584 $581,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $68,138 - $79,832	321 Added 16.31%	2,289 $487,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $10,744 - $11,920	46 Added 2.39%	1,968 $480,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $3,994 - $4,654	18 Added 0.95%	1,922 $478,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $54,744 - $65,190	253 Added 15.32%	1,904 $438,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $234 - $260	1 Added 0.06%	1,651 $420,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $395 - $485	2 Added 0.12%	1,650 $389,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $30,980 - $41,089	170 Added 11.5%	1,648 $334,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $378 - $486	2 Added 0.14%	1,478 $356,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $14,625 - $17,524	-84 Reduced 5.38%	1,476 $286,000
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $14,002 - $16,414	-84 Reduced 5.11%	1,560 $287,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $31,290 - $35,271	173 Added 11.76%	1,644 $312,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $27,116 - $31,654	152 Added 11.52%	1,471 $286,000
Q3 2018 Nov 20, 2018	BUY	$185.29 - $208.89 $185 - $208	1 Added 0.08%	1,319 $273,000
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $58,449 - $65,651	-352 Reduced 21.08%	1,318 $243,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $14,401 - $16,830	-85 Reduced 4.84%	1,670 $285,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $296,226 - $330,975	1,755	1,755 $305,000

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $174B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capstone Financial Advisors, Inc. with notifications on news.

Account

Capstone Financial Advisors, Inc. Amgen Inc Transaction History